Abstract
Oral drug delivery is the largest and the oldest segment of the total drug delivery market. It is the fastest growing and most preferred route for drug administration. Use of hydrophilic matrices for oral extended release of drugs is a common practice in the pharmaceutical industry. This chapter presents different polymer choices for fabrication of monolithic hydrophilic matrices and discusses formulation and manufacturing variables affecting the design and performance of the extended-release product by using selected practical examples.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
1. Lordi, N.G. (1987) Sustained release dosage forms. In: Lachman, L., Lieberman, H.A. and Kanig, J.L. (eds.) The theory and practice of industrial pharmacy, 3rd edn (Indian edn). Varghese Publishing House, Bombay, pp. 430–456.
2. Chiao, C.S.L. and Robinson, J.R. (1995) Sustained-release drug delivery systems. In: Gennaro, A.R. (ed.) Remington: the science and practice of pharmacy, vol. II. Mack Publishing Company, Easton, PA, pp. 1660–1675.
3. Kydonieus, A.F. (1890) Fundamental concepts of controlled release. In: Kydonieus, A.F. (ed.) Controlled release technologies: methods, theory, and applications, vol. I. CRC, Boca Raton, Florida, pp. 1–19.
U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Drug Approval Reports. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Reports.ReportsMenu.
GlaxoSmithKline. Our Histroy [see 1952, online]. http://www.gsk.com/about/histroy-noflash.htm.
6. Sastry, S.V., Nyshadham, J.R. and Fix, J.A. (2000) Recent technological advances in oral drug delivery – a review. Pharm Sci Technol Today, 3, 138–145.
7. Rathbone, M.J., Hadgraft, J. and Roberts, M.S. (eds.) (2003) Modified release drug delivery technology. Marcel Dekker, New York.
8. Buri, P., and Doelker, E. (1980) [Formulation of sustained-release tablets. II. Hydrophilic matrices]. Pharm Acta Helv, 55, 189–197.
9. Conte, U., Colombo, P., Caramella, C. and La Manna, A. (1979) Sustained release nitrofurantoin tablets by direct compression. Farmaco [Prat], 34, 306–316.
10. Conte, U., Colombo, P., Gazzaniga, A., Sangalli, M.E. and La Manna, A. (1988) Swelling-activated drug delivery systems. Biomaterials, 9, 489–493.
11. Lee, B.-J., Ryu, S.-G. and Cui, J.-H. (1999) Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin. Drug Dev Ind Pharm, 25, 493–501.
12. Salomen, J.L. and Doelker, E. (1980) [Formulation of sustained release tablets. I. Inert matrices]. Pharm Acta Helv, 55, 174–182.
13. Wilding, I.R., Davis, S.S., Melia, C.D., Hardy, J.G., Evans, D.F., Short, A.H. and Sparrow, R.A. (1989) Gastrointestinal transit of Sinemet CR in healthy volunteers. Neurology, 39, 53–58.
14. Wilding, I.R., Hardy, J.G., Davis, S.S., Melia, C.D., Evans, D.F., Short, A.H., Sparrow, R.A. and Yeh, K.C. (1991) Characterisation of the in vivo behaviour of a controlled-release formulation of levodopa (Sinemet CR). Clin Neuropharmacol, 14, 305–321.
15. Zhu, Y., Shah, N.H., Malick, A.W., Infeld, M.H. and McGinity, J.W. (2006) Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers. Drug Dev Ind Pharm, 32, 569–583.
USP 29-NF 24. General Chapters: <1090> In vivo bioequivalence guidance – general guidelines. http://www.uspnf.com/uspnf/login.
Inactive ingredient search for approved drug products. http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm.
18. Rowe, R.C., Sheskey, P.J. and Owen, S.C. (2006) Handbook of pharmaceutical excipients, 5th edn. The Pharmaceutical Press, London, UK.
Dow excipients, Methocel™ products. http://www.dow.com/dowexcipients/products/methocel.htm.
USP monographs: hypromellose. http://www.uspnf.com/uspnf/login.
21. Rajabi-Siahboomi, A.R., Bowtell, R.W., Mansfield, P., Davies, M.C. and Melia, C.D. (1996) Structure and behavior in hydrophilic matrix sustained release dosage forms: 4. Studies of water mobility and diffusion coefficients in the gel layer of HPMC tablets using NMR imaging. Pharm Res, 13, 376–380.
22. McCrystal, C.B., Ford, J.L. and Rajabi-Siahboomi, A.R. (1999) Water distribution studies within cellulose ethers using differential scanning calorimetry. 1. Effect of polymer molecular weight and drug addition. J Pharm Sci, 88, 792–796.
Metolose®. http://www.metolose.jp/e/pharmaceutical/metolose.shtml.
Aqualon pharmaceutical excipients. http://www.herc.com/aqualon/pharm/index.html.
25. Dabbagh, M.A., Ford, J.L., Rubinstein, M.H., Hogan, J.E. and Rajabi-Siahboomi, A.R. (1999) Release of propranolol hydrochloride from matrix tablets containing sodium carboxymethylcellulose and hydroxypropylmethylcellulose. Pharm Dev Technol, 4, 313–324.
Carbopol brand polymers. http://www.carbopol.com/.
Dow excipients, POLYOX products. http://www.dow.com/dowexcipients/products/polyox.htm.
28. Timmins, P., Delargy, A.M. and Howard, J.R. (1997) Optimization and characterization of a pH independant extended release hydrophilic matrix tablet. Pharm Dev Technol, 2, 25–31.
29. Kelly, M.L., Tobyn, M.J. and Staniforth, J.N. (2000) Tablet and capsule hydrophilic matrices based on heterodisperse polysaccarides having porosity-independant in vitro release profiles. Pharm Dev Technol, 5, 59–66.
30. Rajabi-Siahboomi, A.R. and Jordan, M.P. (2000) Slow release HPMC matrix systems. Eur Pharm Rev, 5, 21–23.
31. Siepmann, J., Kranz, H., Bodmeier, R. and Peppas, N.A. (1999) HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics. Pharm Res, 16, 1748–1756.
32. Siepmann, J. and Peppas, N.A. (2000) Hydrophilic matrices for controlled drug delivery: an improved mathematical model to predict the resulting drug release kinetics (the “sequential layer” model). Pharm Res, 17, 1290–1298.
33. Siepmann, J. and Peppas, N.A. (2001) Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48, 139–157.
34. Siepmann, J. and Peppas, N.A. (2001) Mathematical modeling of controlled drug delivery. Adv Drug Deliv Rev, 48, 137–138.
35. Siepmann, J., Podual, K., Sriwongjanya, M., Peppas, N.A. and Bodmeier, R. (1999) A new model describing the swelling and drug release kinetics from hydroxypropyl methylcellulose tablets. J Pharm Sci, 88, 65–72.
36. Siepmann, J., Streubel, A. and Peppas, N.A. (2002) Understanding and predicting drug delivery from hydrophilic matrix tablets using the “sequential layer” model. Pharm Res, 19, 306–314.
37. Korsmeyer, R.W., Gurny, R., Doelker, E., Buri, P. and Peppas, N.A. (1983) Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air. J Pharm Sci, 72, 1189–1191.
38. Ford, J.L., Mitchell, K., Rowe, P., Armstrong, D.J., Elliott, P.N.C., Rostron, C. and Hogan, J.E. (1991) Mathematical modelling of drug release from hydroxypropylmethylcellulose matrices: effect of temperature. Int J Pharm, 71, 95–104.
39. Bajwa, G.S., Hoebler, K., Sammon, C., Timmins, P. and Melia, C.D. (2006) Microstructural imaging of early gel layer formation in HPMC matrices. J Pharm Sci, 95, 2145–2157.
40. Timmins, P., Dennis, A.B. and Vyas, K.A. (2002) Biphasic controlled release delivery system for high solubility pharmaceuticals and method. US Pat. 6,475,521.
41. Timmins, P., Dennis, A.B. and Vyas, K.A. (2003) Method of use of a biphasic controlled release delivery system for high solubility pharmaceuticals and method. US Pat. 6,660,300.
Electronic orange book query. http://www.fda.gov/cder/ob/docs/queryai.htm.
International patent applications. http://www.wipo.int/pctdb/en/.
Lohray, B.B. and Tiwari, S.B. (2005) A controlled release delivery system for metformin. WO/2005/123134.
45. Rao, K.V., Devi, P.K. and Buri, P. (1990) Influence of molecular size and water solubility of the solute on its release from swelling and erosion controlled polymeric matrices. J Control Release, 12, 133–141.
Influence of drug solubility on release profiles of drugs from Methocel K4M CR matrices [Internal report]. Colorcon Inc., West Point, PA.
47. Hogan, J.E. (1989) Hydroxypropylmethylcellulose sustained release technology. Drug Dev Ind Pharm, 15, 975–999.
48. Velasco, M.V., Ford, J.L., Rowe, P. and Rajabi-Siahboomi, A.R. (1999) Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J Control Release, 57, 75–85.
49. Mitchell, K., Ford, J.L., Armstrong, D.J., Elliott, P.N., Hogan, J.E. and Rostron, C. (1993) The influence of drugs on the properties of gels and swelling characteristics of matrices containing methylcellulose or hydroxypropylmethylcellulose. Int J Pharm, 100, 165–173.
Brand protection: tablet shape. http://www.colorcon.com/best/c06_tablet_shape.html.
51. Ford, J.L., Rubinstein, M.H., Changela, A. and Hogan, J.E. (1985) The influence of pH on the dissolution of promethazine hydrochloride from hydroxypropyl methylcellulose controlled release tablets. J Pharm Pharmacol, 37, 115P.
52. Levina, M., Gothoskar, A. and Rajabi-Siahboomi, A. (2006) Application of a modelling system in the formulation of extended release hydrophilic matrices. Pharm Technol Eur, 18, 20–26.
53. Alderman, D.A. (1984) A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int J Pharm Tech Prod Manuf, 5, 1–9.
54. Shah, N., Railkar, A.S., Watnanee, P., Zeng, F.-U., Chen, A., Infeld, M.H. and Malick, A.W. (1996) Effects of processing techniques in controlling the release rate and mechanical strength of hydroxypropyl methylcellulose based hydrogel matrices. Eur J Pharm Biopharm, 42, 183–187.
55. Sarkar, N. (1979) Thermal gelation properties of methyl and hydroxypropyl methylcellulose. J Appl Polym Sci, 24, 1073–1087.
56. Levina, M. and Rajabi-Siahboomi, A. (2004) The influence of excipients on drug release from hydroxypropyl methylcellulose matrices. J Pharm Sci, 93, 2746–2754.
57. Horter, D. and Dressman, J.D. (1997) Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev, 25, 3–14.
58. Vashi, V.I. and Meyer, M.C. (1988) Effect of pH on the in vitro dissolution and in vivo absorption of controlled release theophylline in dogs. J Pharm Sci, 77, 760–774.
59. Kohri, N., Miyata, N., Takahashi, M., Endo, H., Iseki, K., Miyazaki, K., Takechi, S. and Nomura, A. (1992) Evaluation of pH-independant sustained release granules of dipyridamole by using gastric-acidity controlled rabbits and human subjects. Int J Pharm, 81, 49–58.
60. Tatavarti, A.S. and Hoag, S.W. (2006) Microenvironmental pH modulation based release enhancement of a weakly basic drug from hydrophilic matrices. J Pharm Sci, 95, 1459–1468.
61. Siepe, S., Herrmann, W., Borchert, H.H., Lueckel, B., Kramer, A., Ries, A. and Gurny, R. (2006) Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: an EPR imaging study. J Control Release, 112, 72–78.
62. Tatavarti, A.S., Mehta, K.A., Augsburger, L.L. and Hoag, S.W. (2004) Influence of methacrylic and acrylic acid polymers on the release performance of weakly basic drugs from sustained release hydrophilic matrices. J Pharm Sci, 93, 2319–2331.
63. Siepe, S., Lueckel, B., Kramer, A., Ries, A. and Gurny, R. (2006) Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH. Int J Pharm, 316, 14–20.
64. Streubel, A., Siepmann, J., Dashevsky, A. and Bodmeier, R. (2000) pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets. J Control Release, 67, 101–110.
65. Gabr, K. (1992) Effect of organic acids on release patterns of weakly basic drugs from inert sustained release matrix tablets. Eur J Pharm Biopharm, 38, 199–202.
66. Varma, M.V.S., Kaushal, A.M. and Garg, S. (2005) Influence of micro-environmental pH on the gel layer behavior and release of a weakly basic drug from various hydrophilic matrices. J Control Release, 103, 499–510.
67. O'Connor, K.M. and Corrigan, O.I. (2002) Effect of a basic organic excipient on the dissolution of diclofenac salts. J Pharm Sci, 91, 2271–2281.
68. Rao, V.M., Engh, K. and Qiu, Y. (2003) Design of pH-independent controlled release matrix tablets for acidic drugs. Int J Pharm, 252, 81–86.
69. Michelucci, J.J., Sherman, D.M. and DeNeale, R.J. (1990) Sustained release etodolac. US Pat. 4,966,768.
70. Riis, T., Bauer-Brandl, A., Wagner, T. and Kranz, H. (2007) pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations. Eur J Pharm Biopharm, 65, 78–84.
71. Ruff, M.D., Kalidindi, S.R. and Sutton, J.J.E. (1994) Pharmaceutical composition containing bupropion hydrochloride and a stabilizer. US Pat. 5,358,970.
Methocel cellulose ethers technical handbook. http://www.dow.com/PublishedLiterature/dh_03e3/09002f13803e32e6.pdf?filepath=methocel/pdfs/noreg/192–01062.pdf&from Page=GetDoc.
73. Mitchell, K., Ford, J.L., Armstrong, D.J., Elliott, P.N., Rostron, C. and Hogan, J.E. (1990) The influence of additives on the cloud point, disintegration and dissolution of hydroxypropyl methylcellulose gels and matrix tablets. Int J Pharm, 66, 233–242.
74. Johnson, J.L., Holinej, J. and Williams, M.D. (1993) Influence of ionic strength on matrix integrity and drug release from hydroxypropyl cellulose compacts. Int J Pharm, 90, 151–159.
Rajabi-Siahboomi, A.R., Nokhodchi, A. and Rubinstein, M.H. (1998) Compaction behaviour of hydrophilic cellulose ether polymers. Pharm Technol, Tableting and Granulation:1998 yearbook, 32–38.
76. Nokhodchi, A. and Rubinstein, M.H. (2001) An overview of the effects of material and process variables on the compaction and compression properties of hydroxypropylmethyl cellulose and ethylcellulose. STP Pharm Sci, 11, 195–202.
77. Liu, C.-H., Chen, S.-C., Kao, Y.-H., Kao, C.-C., Sokoloski, T.D. and Sheu, M.-T. (1993) Properties of hydroxypropylmethylcellulose granules produced by water spraying. Int J Pharm, 100, 241–248.
Dow excipients, foamed binder technology. http://www.dow.com/dowexcipients/applications/foam.htm.
79. Melia, C.D., Rajabi-Siahboomi, A., Hodsdon, A.C., Adler, J. and Mitchell, J.R. (1993) Structure and behavior of hydrophilic matrix sustained release dosage forms. 1. The origin and mechanism of formation of gas bubbles in the hydrated surface layer. Int J Pharm, 100, 263–269.
80. Nokhodchi, A., Ford, J.L., Rowe, P. and Rubinstein, M.H. (1996) The effects of compression rate and force on the compaction properties of different viscosity grades of hydroxypropylmethylcellulose 2208. Int J Pharm, 129, 21–31.
81. Nokhodchi, A., Ford, J.L., Rowe, P.H. and Rubinstein, M.H. (1996) The effect of moisture on the heckel and energy analysis of hydroxypropylmethylcellulose 2208 (HPMC K4M). J Pharm Pharmacol, 48, 1122–1127.
82. Nokhodchi, A., Ford, J.L., Rowe, P.H. and Rubinstein, M.H. (1996) The influence of moisture content on the consolidation properties of hydroxypropylmethylcellulose K4M (HPMC 2208). J Pharm Pharmacol, 48, 1116–1121.
83. Huang, Y., Knanvilkar, K., Moore, A.D. and Hilliard-Lott, M. (2003) Effects of manufacturing variables on in vitro dissolution characteristics of extended release tablets formulated with hydroxypropylmethylcellulose. Drug Dev Ind Pharm, 29, 79–88.
84. Reynolds, T.D., Mitchelle, S.A. and Balwinski, K.M. (2002) Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled release matrix tablets. Drug Dev Ind Pharm, 28, 457–477.
85. Siepmann, J., Kranz, H., Peppas, N.A. and Bodmeier, R. (2000) Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles. Int J Pharm, 201, 151–164.
86. Colombo, P., Conte, U., Gazzaniga, A., Maggi, L., Sangalli, M.E., Peppas, N.A. and Manna, A.L. (1990) Drug release modulation by physical restrictions of matrix swelling. Int J Pharm, 63, 43–48.
87. Colombo, P., Catellani, P., Peppas, N.A., Maggi, L. and Conte, U. (1992) Swellling characteristics of hydrophilic matrices for controlled release: new dimensionless number to describe the swelling and release behavior. Int J Pharm, 88, 99–109.
88. Losi, E., Bettini, R., Santi, P., Sonvico, F., Colombo, G., Lofthus, K., Colombo, P. and Peppas, N.A. (2006) Assemblage of novel release modules for the development of adaptable drug delivery systems. J Control Release, 111, 212–218.
Levina, M., Wan, P., Jordan, M. Rajabi-Siahboomi, A.R. (2003) The influence of film coatings on performance of hypromellose matrices. http://www.colorcon.com/pharma/mod_rel/methocel/literature/infl_fc_hypromel.pdf.
Vuong, H., Levina, M. and Rajabi-Siahboomi, A.R. (2006) The effect of film coating and storage conditions on the performance of metformin HCl 500 mg extended release hypromellose matrices. http://www.colorcon.com/pharma/mod_rel/methocel/literature/fc+stor_perf_metformin.pdf.
Tiwari, S.B., Murthy, T.K., Pai, M.R., Mehta, P.R. and Chowdary, P.B. (2003) Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. AAPS PharmSciTech, 4, Article 31.
Dias, V.D., Gothoskar, A.V., Fegely, K. and Rajabi-Siahboomi, A.R. (2006) Modulation of drug release from hypromellose (HPMC) matrices: suppression of the initial burst effect. http://www.colorcon.com/pharma/mod_rel/methocel/literature/drug_rel_hpmc_burst_suppression.pdf.
93. Takka, S., Rajbhandari, S. and Sakr, A. (2001) Effect of ionic polymers on the release of propranolol hydrochloride from matrix tablets. Eur J Pharm Biopharm, 52, 75–82.
94. Melia, C.D. (1991) Hydrophilic matrix sustained release systems based on polysaccharide carriers. Crit Rev Ther Drug Carrier Syst, 8, 395–421.
95. Bonferoni, M.C., Rossi, S., Ferrari, F., Stavik, E., Pena-Romero, A. and Caramella, C. (2000) Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes. AAPS PharmSciTech, 1, E15.
96. Sinha, V.R., Singh, A., Singh, S. and Bhinge, J.R. (2007) Compression coated systems for colonic delivery of 5-flurouracil. J Pharm Pharmacol, 59, 359–365.
HyperStart® formulation service. http://www.colorcon.com/pharma/mod_rel/methocel/hyperstart_text.html.
98. Fegely, K., Scattergood, L. and Rajabi-Siahboomi, A. (2005) Development of verapamil (240 mg) extended release formulation using Methocel hydrophilic matrices [Application data sheet]. Colorcon Inc., West Point, PA.
Isoptin SR, Knoll, verapamil hydrochloride, antihypertensive agent. http://www.rxmed. com/b.main/b2.pharmaceutical/b2.1.monographs/CPS-%20Monographs/CPS-%20 (General%20Monographs-%20I)/ISOPTIN%20SR.html.
Covera HS (verapamil hydrochloride) extended release tablets, controlled-onset. http://www.pfizer.com/pfizer/download/uspi_covera.pdf.
101. Palmer, F., Levina, M. and Rajabi-Siahboomi, A. (2005) Development of carbamazepine (200 mg) extended release formulation using Methocel hydrophilic matrices [Application data sheet]. Colorcon Inc., West Point, PA.
102. Owen, R.T. (2006) Extended-release carbamazepine for acute bipolar mania: a review. Drugs Today (Barc), 42, 283–289.
Palmer, F., Levina, M. and Rajabi-Siahboomi, A.R. (2005) Investigation of a directly compressible metformin HCl 500 mg extended release formulation based on hypromellose. http://www.colorcon.com/pharma/mod_rel/methocel/literature/metformin_500mg.pdf.
Acknowledgements
The authors thank Kurt Fegely, Dr. Marina Levina, Dr. Abhijit Gothoskar and Viena Diaz (all from Colorcon, Inc.) for their experimental contributions to the data presented in this chapter.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science + Business Media, LLC
About this protocol
Cite this protocol
Tiwari, S.B., Rajabi-Siahboomi, A.R. (2008). Extended-Release Oral Drug Delivery Technologies: Monolithic Matrix Systems. In: Jain, K.K. (eds) Drug Delivery Systems. Methods in Molecular Biology™, vol 437. Humana Press. https://doi.org/10.1007/978-1-59745-210-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-59745-210-6_11
Publisher Name: Humana Press
Print ISBN: 978-1-58829-891-1
Online ISBN: 978-1-59745-210-6
eBook Packages: Springer Protocols